蒙诺格拉姆科技更新了其人工智能膝关节置换系统的FDA提交,旨在避免临床试验. Monogram Technologies updates FDA submission for its AI knee replacement system, aiming to avoid clinical trials.

专注于骨科手术的AI驱动机器人公司Monogram Technologies在与该机构进行积极会议后, 更新了其对Mbo's TKA系统的510k) 提交给FDA. Monogram Technologies, an AI-driven robotics firm focused on orthopedic surgery, has updated its 510(k) submission to the FDA for its mBôs TKA System after a positive meeting with the agency. 该公司认为已经充分解决了FDA的担忧,并预计将在2025年第一季度提交全面的回应,旨在避免临床数据请求. The company believes it has adequately addressed FDA concerns and expects to submit a comprehensive response in the first quarter of 2025, aiming to avoid a clinical data request. 该系统旨在提高膝盖替换的精确度。 The system is designed to improve precision in knee replacements.